Wolverine Peptide — Passes The Safety Check
High-Dose IV BPC-157 Safety Pilot Study: Zero Side Effects at 20–40× Typical Biohacking Levels (New 2025 Data) If you’ve been following the peptide scene, BPC-157 has been one of the most talked-about compounds for tissue repair, gut health, and recovery. But one persistent knock has always been the lack of solid human safety data—especially at the kinds of doses people actually experiment with. A brand-new pilot study just changed that. Published in 2025, it tested intravenous BPC-157 at doses that make standard biohacking protocols look tiny. And the results? Clean. No side effects, no lab abnormalities. Here’s exactly what happened, why it matters, and why you should still approach it with eyes wide open. Quick Background on BPC-157 BPC-157 (Body Protection Compound-157) is a 15-amino-acid synthetic peptide modeled after a protective protein found in human gastric juice. Animal research (hundreds of studies) has shown impressive effects on tendon healing, muscle ...